[Individual glycoside therapy using serum concentration determination in canine heart failure].
32 dogs with congestive heart failure without sufficient reaction to a standardized therapy with glycosides are treated with an individual glycoside dose. The therapy is controlled by the serum concentration of the cardiac glycoside. The influence of additional diseases and medications is demonstrated. Finally a rule for the evaluation of the therapeutic glycoside dose is given.
Staudacher
G
G
D000818:Animals; D002301:Cardiac Glycosides / Q000097:blood / Q000627:therapeutic use*; D004074:Digitoxin / Q000097:blood / Q000627:therapeutic use; D004077:Digoxin / Q000097:blood / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D006333:Heart Failure / Q000188:drug therapy / Q000662:veterinary*
D002301:Cardiac Glycosides; D004077:Digoxin; D004074:Digitoxin
Individuelle Glykosidtherapie mittels Serumkonzentrationsbestimmung bei der Herzinsuffizienz des Hundes.